Vanessa L Neergheen1, Matthew Topel2, Miriam E Van Dyke1, Samaah Sullivan1, Priscilla E Pemu3, Gary H Gibbons4, Viola Vaccarino5, Arshed A Quyyumi2, Tené T Lewis6. 1. Rollins School of Public Health, Emory University, Atlanta, GA, United States. 2. Division of Cardiology, Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA, United States. 3. Morehouse School of Medicine, Atlanta, GA, United States. 4. National Heart, Lung, and Blood Institute, Bethesda, MD, United States. 5. Rollins School of Public Health, Emory University, Atlanta, GA, United States; Division of Cardiology, Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA, United States. 6. Rollins School of Public Health, Emory University, Atlanta, GA, United States. Electronic address: tene.t.lewis@emory.edu.
Abstract
INTRODUCTION: Social cohesion is a positive neighborhood characteristic defined by feelings of connectedness and solidarity within a community. Studies have found significant associations between social cohesion and cardiovascular disease (CVD) risk factors and outcomes. Inflammation is one potential physiological pathway linking social cohesion to CVD development, but few studies have evaluated the relationship between social cohesion and inflammatory biomarkers. Prior research has also established that race and gender can modify the effects of neighborhood features, including social cohesion, on CVD risk factors and outcomes. This study aimed to examine the association between social cohesion and the inflammatory biomarkers interleukin-6 (IL-6) and C-reactive protein (CRP) in a cohort of African American and White women and men. MATERIALS AND METHODS: Data from the Morehouse and Emory Team Up to Eliminate Health Disparities (META-Health) Study were used to assess the association between social cohesion and inflammation among African American (n = 203) and White (n = 176) adults from the Atlanta metropolitan area. Social cohesion was measured using the social cohesion subscale from the Neighborhood Health Questionnaire. Inflammatory biomarkers were measured from plasma frozen at -70 °C. Multivariable linear regression analyses were conducted, controlling for demographic, clinical, behavioral, and psychosocial factors sequentially. Interaction by race and gender was also examined. RESULTS: In models adjusted for age, race, gender, and education, social cohesion was significantly associated with lower levels of IL-6 (β = -0.06, p = 0.03). There was a significant race × social cohesion interaction (p = 0.04), and a marginally significant gender × race × social cohesion interaction (p = 0.09). In race-stratified models controlling for age, gender, and education, social cohesion was associated with lower IL-6 levels in African Americans (β = -0.11, p = 0.01), but not Whites (β = 0.01, p = 0.91). In fully adjusted race- and gender-stratified models, social cohesion was associated with lower levels of IL-6 in African American women only (β = -0.15, p = 0.003). CRP was not associated with social cohesion in fully adjusted models. CONCLUSION: The association between social cohesion and lower levels of IL-6 is modified by gender and race, with the strongest association emerging for African American women. Although the pathways through which social cohesion impacts inflammation remain unclear, it is possible that for African American women social cohesion manifests through neighborhood networks.
INTRODUCTION: Social cohesion is a positive neighborhood characteristic defined by feelings of connectedness and solidarity within a community. Studies have found significant associations between social cohesion and cardiovascular disease (CVD) risk factors and outcomes. Inflammation is one potential physiological pathway linking social cohesion to CVD development, but few studies have evaluated the relationship between social cohesion and inflammatory biomarkers. Prior research has also established that race and gender can modify the effects of neighborhood features, including social cohesion, on CVD risk factors and outcomes. This study aimed to examine the association between social cohesion and the inflammatory biomarkers interleukin-6 (IL-6) and C-reactive protein (CRP) in a cohort of African American and White women and men. MATERIALS AND METHODS: Data from the Morehouse and Emory Team Up to Eliminate Health Disparities (META-Health) Study were used to assess the association between social cohesion and inflammation among African American (n = 203) and White (n = 176) adults from the Atlanta metropolitan area. Social cohesion was measured using the social cohesion subscale from the Neighborhood Health Questionnaire. Inflammatory biomarkers were measured from plasma frozen at -70 °C. Multivariable linear regression analyses were conducted, controlling for demographic, clinical, behavioral, and psychosocial factors sequentially. Interaction by race and gender was also examined. RESULTS: In models adjusted for age, race, gender, and education, social cohesion was significantly associated with lower levels of IL-6 (β = -0.06, p = 0.03). There was a significant race × social cohesion interaction (p = 0.04), and a marginally significant gender × race × social cohesion interaction (p = 0.09). In race-stratified models controlling for age, gender, and education, social cohesion was associated with lower IL-6 levels in African Americans (β = -0.11, p = 0.01), but not Whites (β = 0.01, p = 0.91). In fully adjusted race- and gender-stratified models, social cohesion was associated with lower levels of IL-6 in African American women only (β = -0.15, p = 0.003). CRP was not associated with social cohesion in fully adjusted models. CONCLUSION: The association between social cohesion and lower levels of IL-6 is modified by gender and race, with the strongest association emerging for African American women. Although the pathways through which social cohesion impacts inflammation remain unclear, it is possible that for African American women social cohesion manifests through neighborhood networks.
Authors: Cari Jo Clark; Hongfei Guo; Scott Lunos; Neelum T Aggarwal; Todd Beck; Denis A Evans; Carlos Mendes de Leon; Susan A Everson-Rose Journal: Stroke Date: 2011-04-14 Impact factor: 7.914
Authors: Anne M Kavanagh; Rebecca Bentley; Gavin Turrell; Dorothy H Broom; S V Subramanian Journal: J Epidemiol Community Health Date: 2006-06 Impact factor: 3.710
Authors: Samson Y Gebreab; Pia Riestra; Amadou Gaye; Rumana J Khan; Ruihua Xu; Adam R Davis; Rakale C Quarells; Sharon K Davis; Gary H Gibbons Journal: Psychoneuroendocrinology Date: 2016-04-01 Impact factor: 4.905
Authors: Ann W Nguyen; Harry Owen Taylor; Karen D Lincoln; Weidi Qin; Tyrone Hamler; Fei Wang; Uchechi A Mitchell Journal: J Gerontol A Biol Sci Med Sci Date: 2022-02-03 Impact factor: 6.053
Authors: Shabatun J Islam; Jeong Hwan Kim; Peter Baltrus; Matthew L Topel; Chang Liu; Yi-An Ko; Mahasin S Mujahid; Viola Vaccarino; Mario Sims; Mohamed Mubasher; Ahsan Khan; Kiran Ejaz; Charles Searles; Sandra Dunbar; Priscilla Pemu; Herman A Taylor; Arshed A Quyyumi; Tené T Lewis Journal: Ann Epidemiol Date: 2020-12-05 Impact factor: 3.797
Authors: Dana M Alhasan; Symielle A Gaston; W Braxton Jackson; Patrice C Williams; Ichiro Kawachi; Chandra L Jackson Journal: Int J Environ Res Public Health Date: 2020-12-17 Impact factor: 3.390
Authors: Erin Lebow-Skelley; Lynne Young; Yomi Noibi; Karla Blaginin; Margaret Hooker; Dana Williamson; Martha Scott Tomlinson; Michelle C Kegler; Melanie A Pearson Journal: Front Public Health Date: 2022-04-12